Corona Virus (2019 n-CoV) – A review article

Authors

Dr.S. Valarmathi
editorijipsr@gmail.com
Department of Pharmaceutics, Annai Veilankanni‟s College of Pharmacy, Chennai, 600015, Tamil Nadu, India
Dr.M. Senthil Kumar Department of Pharmaceutics, Annai Veilankanni‟s College of Pharmacy, Chennai, 600015, Tamil Nadu, India
Johnsy Mary Department of Pharmaceutics, Annai Veilankanni‟s College of Pharmacy, Chennai, 600015, Tamil Nadu, India
Vignesh Sharma Department of Pharmaceutics, Annai Veilankanni‟s College of Pharmacy, Chennai, 600015, Tamil Nadu, India
Johnse Rani Department of Pharmaceutics, Annai Veilankanni‟s College of Pharmacy, Chennai, 600015, Tamil Nadu, India
Guhan Department of Pharmaceutics, Annai Veilankanni‟s College of Pharmacy, Chennai, 600015, Tamil Nadu, India

Wuhan, China, Animal, 2019-nCoV, Vaccine.

The corona virus otherwise called as Wuhan corona virus is found to be very dangerous virus which causes

complete respiratory failure. The corona virus was designated as “2019 nCoV” several steps was taken by the china

to develop vaccines against corona virus. So many vaccines are under animal testing to prevent the effects of corona

virus. The first human infection by corona virus was occurred in December 2019. The acute respiratory disease

remains unclear and death rate is increased. World Health Organization (WHO) led by Director General Dr. Tedros

Adhanom Ghebreyesus, focussed on improvement measures in Wuhan, to strengthen public health measure and to

conduct studies on virus. The measures will advance scientific understanding of the virus and lead to the

development of vaccines and treatment of corona virus infected people.

Dimensions